Tag: urine drug test
New to drug testing: Synthetic stimulants
Synthetic compounds change frequently and our scientific experts must monitor, and adjust our testing panels to an ever-changing list of substances.
Ask the experts: The benefits of drug testing
Companies – large and small, public and private, regulated and non-regulated – would benefit from a workplace drug and alcohol testing program.
New to drug testing: Cold medicine’s effect on drug test results
Some cold medicines contain drugs such as hydrocodone, codeine and sympathomimetics, which have been reported to affect drug test results.
New to drug testing: Complete line of products and services
Our Complete Line of Drug Testing Solutions brochure highlights all of our products & services which can be used to help build a drug testing program.
Gain insights from 25 years of drug testing data
Our webinar features milestones and lessons learned from an unprecedented analysis of more than 125 million urine drug tests from the past 25 years.
New to drug testing: Synthetic marijuana
In our ongoing quest to help keep workplaces drug-free, we now offer a synthetic cannabinoids panel to test for commonly detected compounds.
Drug Testing Index: A look at 2008 – 2013
The Quest Diagnostics Drug Testing Index reveals insights into patterns of drug use among the American workforce. As we celebrate our 30th anniversary, we take a deeper look at overall positivity rates and key milestones from 2008 to 2013.
Quest Diagnostics tests for synthetic cannabinoids
Quest Diagnostics now offers a synthetic cannabinoids panel testing for AM-2201, JWH-018, JWH-019, JWH-073, JWH-250, UR-144 and XLR11 compounds.
Drug Testing Index: A look at 2003 – 2007
The Quest Diagnostics Drug Testing Index reveals insights into patterns of drug use among the American workforce. As we celebrate our 30th anniversary, we take a deeper look at overall positivity rates and key milestones from 2003 to 2007.
Drug Testing Index: A look at 1998 – 2002
The Quest Diagnostics Drug Testing Index reveals insights into patterns of drug use among the American workforce. As we celebrate our 30th anniversary, we take a deeper look at overall positivity rates and key milestones from 1998 to 2002.
